 |
|
COMMENTS AND OPINIONS
HEALTH CARE REFORM
Pharmacists Are Key to Enhancing Benefit Risk for Medicines—Reply
Michael D. Murray, PharmD, MPH
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In reply
Dr Banerjee describes the need for improved risk minimization plans for marketed drugs and the relevance of appropriate prescribing, pharmacist education, and technology in improving medication safety. Because of the complexity of pharmacotherapy and our modest understanding of the risks of marketed drugs, approaches to risk minimization involving health care providers (physicians, pharmacists, and nurses) and technology, such as the Internet, could reduce threats to medication safety. These efforts are of global importance and have captured the attention of drug policy experts and regulatory agencies, particularly in the European Union, the Middle East, and the United States.
Nonetheless, because of limited support to improve prescribing practices, limited time spent by health care providers educating patients about their medications, and a still evolving informatics infrastructure, patients often slip through the existing safety net and experience drug-related problems. As indicated by the results of our . . . [Full Text of this Article]
AUTHOR INFORMATION
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease
Michael D. Murray, Mary E. Ritchey, Jingwei Wu, and Wanzhu Tu
Arch Intern Med. 2009;169(8):757-763.
ABSTRACT
| FULL TEXT
RELATED LETTER
Pharmacists Are Key to Enhancing Benefit Risk for Medicines
Anjan K. Banerjee
Arch Intern Med. 2009;169(18):1723.
EXTRACT
| FULL TEXT
|
